Research Webinars, • 8/7/24 Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Previous Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study Next An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD You Might Also Like Halie's Story RUNX1 Deficiency in Megakaryopoiesis: Discovering Therapeutics for RUNX1 Haploinsufficiency RRP: One Goal Prevent Cancer How Does a Genetic Mutation Lead to Cancer RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham
Research Webinars, • 8/7/24 Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML Previous Latest Research Findings From the Ongoing NIH RUNX1 Natural History Study Next An Approach to Screening Drugs for Preventing Disease Progression in Patients with RUNX1-FPD You Might Also Like Halie's Story RUNX1 Deficiency in Megakaryopoiesis: Discovering Therapeutics for RUNX1 Haploinsufficiency RRP: One Goal Prevent Cancer How Does a Genetic Mutation Lead to Cancer RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham
